Zenith Healthcare Limited

zenithhealthcare.com

Zenith Healthcare Limited (ZHL) is a listed public Limited Company managed by a Professional Chartered Accountant since 20 years. Situated nearby leading pharmaceutical hub of India in Ahmedabad, Gujarat, INDIA. Zenith Healthcare Limited is one of India’s leading pharmaceutical companies with a strong presence in the country’s domestic formulations market.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

KYOWA KIRIN EXPANDS LICENSE AGREEMENT WITH SYNAFFIX AND TAKES EXCLUSIVE TARGET RIGHTS BASED ON LATEST POSITIVE ADC DATA

Synaffix | July 01, 2022

news image

Synaffix B.V. a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates with best-in-class therapeutic index, today announces that Kyowa Kirin Co., Ltd.a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, has expanded the license agreement with Synaffix by adding a third ADC target to its research evaluation and development effor...

Read More

Pharmacy Market

M-PHARMA AND KYOWA KIRIN SIGN EXCLUSIVE LICENSE AGREEMENT FOR COMMERCIALIZATION OF ILOFOTASE ALFA IN JAPAN

AM-Pharma | September 08, 2021

news image

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, and Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, today announced that they have entered into an exclusive license agreement under which Kyowa Kirin gains the rights to develop and commercialize ilofotase alfa, AM-Pharma’s proprietary recombinant human alkaline phosphatase. ...

Read More

Pharmacy Market

CYTEL ACQUIRES FRENCH GROUP STÈVE CONSULTANTS TO FURTHER EXPAND VALUE EVIDENCE AND REAL-WORLD ANALYTICS CAPABILITIES

Businesswire | July 07, 2023

news image

Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR). The acquisition further expands Cytel’s real-world & advanced analytics (RWAA) capabilities, giving sponsors an expanded global offering, with access to additional specialists and localized expertise. This acquisition continues the company&rsquo...

Read More

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

news image

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More
news image

Business Insights

KYOWA KIRIN EXPANDS LICENSE AGREEMENT WITH SYNAFFIX AND TAKES EXCLUSIVE TARGET RIGHTS BASED ON LATEST POSITIVE ADC DATA

Synaffix | July 01, 2022

Synaffix B.V. a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates with best-in-class therapeutic index, today announces that Kyowa Kirin Co., Ltd.a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, has expanded the license agreement with Synaffix by adding a third ADC target to its research evaluation and development effor...

Read More
news image

Pharmacy Market

M-PHARMA AND KYOWA KIRIN SIGN EXCLUSIVE LICENSE AGREEMENT FOR COMMERCIALIZATION OF ILOFOTASE ALFA IN JAPAN

AM-Pharma | September 08, 2021

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, and Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, today announced that they have entered into an exclusive license agreement under which Kyowa Kirin gains the rights to develop and commercialize ilofotase alfa, AM-Pharma’s proprietary recombinant human alkaline phosphatase. ...

Read More
news image

Pharmacy Market

CYTEL ACQUIRES FRENCH GROUP STÈVE CONSULTANTS TO FURTHER EXPAND VALUE EVIDENCE AND REAL-WORLD ANALYTICS CAPABILITIES

Businesswire | July 07, 2023

Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR). The acquisition further expands Cytel’s real-world & advanced analytics (RWAA) capabilities, giving sponsors an expanded global offering, with access to additional specialists and localized expertise. This acquisition continues the company&rsquo...

Read More
news image

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us